Adjustable Continence Therapy for the treatment of male stress urinary incontinence: A single-centre study
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 41 (4) , 324-328
Abstract
Objective. To evaluate the Adjustable Continence Therapy (ProACT™) device, a new device for the treatment of male stress urinary incontinence resulting from compromised sphincteric function. Material and methods. A total of 64 males with post-prostatectomy incontinence underwent ProACT implantation. Efficacy was assessed by means of a daily pad count, a direct visual stress test, administration of the Incontinence Quality of Life (IQOL) and patient global impression (PGI) questionnaires and use of a visual analogue scale (VAS) to assess improvement in incontinence. These assessments were performed at baseline, 1, 3, 6 and 12 months after the procedure and annually thereafter. Results. The pad count declined from a median of 5.2 at baseline to 2 at 6 months and to 1.54 at 12 months. The median baseline IQOL score was 31.7, and this improved to 62.5 at 6 months and to 71.1 at 12 months. In terms of postoperative daily pad usage, 43 patients (67%) were considered to be dry, 10 (15%) improved and 11 (17%) unchanged. In terms of the post operative PGI score, 42 patients (66%) considered themselves to have improved greatly, 10 (16%) to have improved quite a lot, 6 (9%) to have improved slightly and 6 (9%) to be unchanged. The average improvement based on the VAS was 80%. The average number of postoperative adjustments was three (range zero to nine). Complications included infection (2/64; 3%), erosion of balloons (5/64; 7.6%), migration (2/64; 3%) and balloon deflation (2/64; 3%). Device removal was required in 9/64 patients (14%) but was easily achieved using local anaesthesia, and this thus permitted further therapeutic intervention. New balloons were implanted following endoscopic confirmation of urethral healing. Conclusion. The ProACT device represents an efficacious treatment modality, which has an acceptable complication rate for a difficult group of patients.Keywords
This publication has 14 references indexed in Scilit:
- Prospective study evaluating efficacy and safety of Adjustable Continence Therapy (ProACT) for post radical prostatectomy urinary incontinenceUrology, 2006
- Urinary incontinence and voiding dysfunction after radical retropubic prostatectomy (prospective urodynamic study)Neurourology and Urodynamics, 2005
- Treatment of incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapyBJU International, 2005
- Validation of two global impression questionnaires for incontinenceAmerican Journal of Obstetrics and Gynecology, 2003
- Assessment of the intrinsic urethral sphincter component function in postprostatectomy urinary incontinenceNeurourology and Urodynamics, 2002
- LONG-TERM CONTINENCE AND PATIENT SATISFACTION AFTER ARTIFICIAL SPHINCTER IMPLANTATION FOR URINARY INCONTINENCE AFTER PROSTATECTOMYJournal of Urology, 2001
- A Review of the Complications and Results of Implantation of the AMS Artificial Urinary SphincterEuropean Urology, 1999
- Quality of life of persons with urinary incontinence: Development of a new measureUrology, 1996
- Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 YearsJournal of Urology, 1994
- Patient-re ported complications and follow-up treatment after radical prostatectomyUrology, 1993